Opus Point Partners Management »

Audentes Therapeutics shares owned by Opus Point Partners Management

Quarter-by-quarter ownership of Audentes Therapeutics shares owned by Opus Point Partners Management from 13F filings

Historical chart of Opus Point Partners Management investment in Audentes Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Audentes Therapeutics held by Opus Point Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Audentes Therapeutics by Opus Point Partners Management

Quarter filed Position value Share count Share price at filing
2019-09-30 $487k 17k 28.09
2019-06-30 $656k 17k 37.83
2019-03-31 $677k 17k 39.04

More positions owned by Opus Point Partners Management

iShares NASDAQ Biotechnology Index (IBB)
Direxion Shs Etf Tr sp biotch bl
Mettler-Toledo International (MTD)
Bristol Myers Squibb (BMY)
Seattle Genetics
Illumina (ILMN)
Vertex Pharmaceuticals Incorporated (VRTX)
Ionis Pharmaceuticals (IONS)
Alnylam Pharmaceuticals (ALNY)
Alexion Pharmaceuticals
Qiagen Nv
Spark Therapeutics
Fortress Biotech
Proqr Thrapeutics N V shs euro (PRQR)
Incyte Corporation (INCY)

View all positions for Opus Point Partners Management